ISHTAR HODE: Open Payments
NPI 1033677539 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 60 payments from 17 companies in 2025. Trend: 2023 $1,406 · 2024 $1,497 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $355 |
| Novo Nordisk Inc | 12 | $247 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $201 |
| PFIZER INC. | 4 | $104 |
| ABBVIE INC. | 4 | $104 |
| Lilly USA, LLC | 4 | $74 |
| Dexcom, Inc. | 3 | $65 |
| Amgen Inc. | 4 | $60 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $40 |
Products named: FARXIGA, Kerendia, AIRSUPRA, Wegovy, VRAYLAR, Ozempic, Dexcom G6 Transmitter, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
